Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 461.92 Million | USD 954.63 Million | 8.40% | 2023 |
The global fertility test market size was worth around USD 461.92 million in 2023 and is predicted to grow to around USD 954.63 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.40% between 2024 and 2032.
This report analyzes and estimates the Fertility Test market at global, regional, and country levels. The research study provides historic data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The report offers detailed insights into the Fertility Test market drivers and restraints along with their impact analysis at a global level from 2018 to 2032.
A fertility test is a medical evaluation aimed at determining the reproductive health and fertility potential of individuals or couples trying to conceive. These tests are designed to identify any underlying issues that might be affecting one's ability to conceive naturally. Fertility tests can be conducted for both men and women, as infertility issues can arise from either partner. For women, common tests include blood tests to check hormone levels such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), and anti-Müllerian hormone (AMH), which provide insights into ovarian reserve and ovulation function. Other tests may involve imaging techniques like transvaginal ultrasound to examine the ovaries and uterus, or hysterosalpingography (HSG) to assess the fallopian tubes' patency. Additionally, ovulation tracking and endometrial biopsy can help evaluate the ovulation process and the uterine lining's receptivity.
The report covers an in-depth analysis of the strategies adopted by major competitors in the global Fertility Test market. To understand the competitive landscape in the global Fertility Test, an analysis of Porter’s Five Forces model is also included. The research study comprises of market attractiveness analysis, wherein all the segments are benchmarked on the basis of their market size and growth rate.
The rising first-time pregnancy age, decline in the fertility rate among men amid women, and increasing cases of PCOS are the primary factors anticipated to propel the growth of the global Fertility Test market. Furthermore, the development of innovative and advanced ovulation monitors and growing awareness about fertility testing in emerging and developed regions will support the market growth during the forecast period. However, the unconfirmed precision of urine-based ovulation monitors and other ovulation prediction kits is expected to hamper the market growth in the coming years.
The research study provides a decisive view of the global Fertility Test market based on Product, Mode of Purchase, Application, End-User, and Region. All the segments of the market have been analyzed based on past, present, and future trends. The market is estimated from 2024 to 2032.
On the basis of product, the market for fertility tests is divided into Ovulation Predictor Kits (OPK) and Fertility Monitors (Urine & Saliva-based).
Based on the mode of purchase, the global Fertility Testing market is segregated into OTC and Prescription.
In terms of application, the market is segmented into Female Fertility Testing and Male Fertility Testing.
By end-user, the market is sectored into Homecare Settings, Fertility Clinics, Hospital, and Others.
Report Attributes | Report Details |
---|---|
Report Name | Fertility Test Market Research Report |
Market Size in 2023 | USD 461.92 Million |
Market Forecast in 2032 | USD 954.63 Million |
Growth Rate | CAGR of 8.40% |
Number of Pages | 110 |
Forecast Units | Value (USD Million), and Volume (Units) |
Key Companies Covered | Church & Dwight Co., Inc., SPD Swiss Precision Diagnostics GmbH, Valley Electronics GmbH, Geratherm Medical AG, Prestige Brands Holdings, Inc., and others. |
Segments Covered | By Product, By Mode of Purchase, By Application, By End Use, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segmentation comprises the past, present, and estimated demand for the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. The regional segment is further split into the U.S., Canada, Mexico, the UK, France, Germany, China, Japan, India, South Korea, Brazil, and Argentina among others.
North America dominated the global fertility test market in 2018. The reduction in fertility rate, increasing early age pregnancies, and the existence of polycystic ovary syndrome (PCOS) among North American women are some of the primary factors contributing to the large share of the regional segment. Furthermore, the increasing awareness about the advantages of ovulation monitors via marketing campaigns, social media, and e-commerce sites along with the growing utilization of fertility monitoring equipment for contraception are escalating the popularity of fertility tests in North America.
Some of the key players in the global Fertility Test market include
By Product
By Mode of Purchase
By Application
By End-User
Global Fertility Test Market: By Regional Segmentation Analysis
FrequentlyAsked Questions
A fertility test is a medical evaluation aimed at determining the reproductive health and fertility potential of individuals or couples trying to conceive.
The factors such as cost-effectiveness, high efficacy, high preference for these kits, and rising cases of first-time pregnancies in women are expected to propel the global Fertility Testing market.
According to the report, global demand for the Fertility Test market was valued over USD 461.92 million in 2022 and is expected to reach a CAGR of 8.40% between 2024 to 2032.
North America has been leading the global fertility test market and is anticipated to continue on the dominant position in the years to come.
Some of the key players of the global Fertility Test market include Church & Dwight Co., Inc., SPD Swiss Precision Diagnostics GmbH, Valley Electronics GmbH, Geratherm Medical AG, Prestige Brands Holdings, Inc., and others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed